MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.8000
-0.2000 (-20.00%)
At close: Feb 4, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 3.84 million as of February 9, 2026. Its market cap has decreased by -3.86% in one year.
Market Cap
3.84M
Enterprise Value
5.82M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.80
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 3.84M, a decrease of -95.19%. That is a compound annual growth rate of -66.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 3.84M | -35.97% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 7.26M |
| Restart Life Sciences | 5.94M |
| Aptose Biosciences | 5.69M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| Gemina Laboratories | 4.59M |
| XORTX Therapeutics | 4.04M |
| Appili Therapeutics | 3.21M |